Hemochron
Clotting time, at the bedside.
The Hemochron Signature Elite runs single-use Hemochron Jr. test cuvettes that measure fibrin clot formation in whole blood. One instrument covers high- and low-range heparin monitoring (ACT+ and ACT-LR) and PT and APTT on fresh or citrated samples. Built-in electronic QC, cuvette and QC expiry lockouts, operator tracking and a barcode scanner support compliance, and results transfer by Ethernet to POCT1-A data managers.
Key specifications
Why the Hemochron Signature Elite
One analyser, full menu
ACT+ and ACT-LR cover high- and low-dose heparin, while PT and APTT cover both coagulation pathways, on fresh or citrated whole blood.
Low-range ACT
Werfen indicates the ACT-LR assay for low-dose heparin in ECLS, PCI, vascular, neurointerventional and dialysis procedures, with a 0.0–2.5 U/mL range.
Built for compliance
Automatic electronic QC, lockouts for expired cuvettes and QC, and operator lockout help keep point-of-care testing within policy.
Connected results
Ethernet and POCT1-A connectivity send results to the hospital data manager, and the instrument stores 600 patient and 600 QC results.
Where it is used
Cardiovascular operating rooms, cardiac catheterisation labs, interventional neuroradiology, emergency departments, intensive care, trauma surgery and anticoagulation clinics.
In the box
Hemochron Signature Elite analyser with charger. Test cuvettes (ACT+, ACT-LR, PT, APTT, fresh and citrated), liquid controls and data management software are ordered separately. Pack sizes and configurations are confirmed with the quotation.
Clearance & compliance
FDA 510(k) cleared K050016 (International Technidyne Corp., 10 Feb 2005) and K193041 (Accriva Diagnostics, 22 Nov 2019); 21 CFR 864.5425, Class II, product code JPA; for in vitro diagnostic use · CE marked IVD: Hemochron Signature Elite (REF ELITE, ELITEINT, RPM-CD) registered in EUDAMED by Accriva Diagnostics, Inc., IVDR Class A. Supplied subject to registration in each destination country (MOHAP, DoH, DHA, SFDA or the equivalent authority). Certificates, declarations of conformity, IFUs and registration documents are provided with every quotation. Specifications are indicative and subject to manufacturer change.
Where a country has an official agent or authorised distributor, we source the item through it — or directly from the manufacturer if necessary. Product names, trademarks and images belong to their respective owners.
Questions
Is the Hemochron Signature Elite available in the UAE and the GCC?
KGG sources the Hemochron Signature Elite and its test cuvettes on request for hospitals and cardiac centres in the UAE, Saudi Arabia, Qatar, Kuwait, Bahrain and Oman. It is supplied subject to registration in each destination country, and availability is confirmed with each quotation.
How do I get a price?
Add it to your quote list or use Request a quote. We reply with pricing, lead time and the documents for your country, and can quote cuvettes and controls with the analyser.
Which cuvette do I need?
ACT+ for high-dose heparin (1.0–6.0 U/mL), ACT-LR for low-dose heparin (0.0–2.5 U/mL), and PT or APTT for coagulation screening, each in fresh or citrated versions.
Are the cuvettes medicines?
No. Hemochron cuvettes are in vitro diagnostic reagents used with the analyser. Shipping and storage conditions differ by assay and are confirmed with the quotation.
Is there an affected cuvette recall?
In November 2025 certain ACT-LR cuvette lots were recalled in the USA for a possible sharp-edged foreign object. We confirm with Werfen that quoted lots are unaffected.
Can it connect to our hospital system?
Yes. It connects directly by Ethernet and is POCT1-A compliant, so results can pass to major point-of-care data management systems.
Request a quote
Get pricing for the Hemochron Signature Elite.
Tell us the quantity, delivery city and whether you are ordering for a facility, a team or a patient. We reply with pricing, lead time and the regulatory documents for your country.
English 
العربية